Reumatoloxía
Instituto de Investigación Sanitaria Gregorio Marañón
Madrid, EspañaPublicacións en colaboración con investigadores/as de Instituto de Investigación Sanitaria Gregorio Marañón (5)
2024
-
Early identification of golimumab-treated patients with higher likelihood of long-term retention
Frontiers in Immunology, Vol. 15
-
Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry
Annals of the Rheumatic Diseases, Vol. 83, Núm. 9, pp. 1189-1199
2022
-
Retention of golimumab treatment following discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases: An analysis of the Spanish BIOBADASER registry
Musculoskeletal Care, Vol. 20, Núm. 2, pp. 403-407
2021
-
Safety in the use of ultrasound in rheumatology during the COVID-19 Pandemic. Spanish Society of Rheumatology positioning paper
Reumatologia Clinica, Vol. 17, Núm. 5, pp. 284-289
2020
-
Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: A multicentric matched cohort study
Annals of the Rheumatic Diseases, Vol. 79, Núm. 12, pp. 1544-1549